This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fitzgerald, K. Articles by Craig, R. M. Search for Related Content PubMed PubMed Citation Articles by Fitzgerald, K. Articles by Craig, R. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB MANGANESE COMPOUNDS MANGANESE, ELEMENTAL Social Bookmarking                         What's this?

Hypermanganesemia in Patients Receiving Total Parenteral Nutrition

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Vida Mikalunas, MSN

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Halina Rubin, RPh. BCNSP

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Roberta McCarthy, RD, CNSD

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Arvydas Vanagunas, MD

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Robert M. Craig, MD

Nutritional Support Service and the Gastroenterology Division, Northwestern Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois

Background: Manganese is one of the trace elements that is routinely administered to total parenteral nutrition (TPN) patients. The recommended daily IV dosage ranges from 100 to 800 µg. We have used 500 µg daily. Recent reports have suggested neurologic symptoms seen in some patients receiving home parenteral nutrition (HPN) may be due to hypermanganesemia. Therefore, HPN patients and some short-term inpatients receiving TPN were studied to ascertain the relationship between dose and blood levels. Methods: Red blood cell manganese levels were obtained by atomic absorptiometry. Results: The levels in 36 hospitalized, short-term patients obtained within 48 hours of initiating TPN were all normal. The 30 patients receiving TPN from 3 to 30 days had levels that ranged from 4.8 to 28 µg/L (normal, 11 to 23 µg/L). Two patients had abnormal levels, at days 14 and 18. Fifteen of the 21 patients receiving inpatient TPN or HPN for 36 to 5075 days had elevated Mn levels. Only one patient with hypermanganesemia, an inpatient, had abnormal biochemical liver tests (bilirubin and alkaline phosphatase). One of the patients with a high level had some vestibular symptoms attributed to aminoglycoside use and had increased signal density in the globus pallidus on T1-weighted images on magnetic resonance imaging (MRI). A second patient with Mn levels twice normal had no neurologic symptoms, but had similar MRI findings. A third had some basal ganglia symptoms, confirmed by a neurologic evaluation, seizures, and very high Mn levels. The MRI showed no signal enhancement, but motion artifacts limited the study technically. Conclusions: Hypermanganesemia is seen in HPN patients receiving 500 µg manganese daily and may have resulted in some neurologic damage in three patients. Hypermanganesemia is sometimes seen after a short course of TPN in inpatients, as early as 14 days. Patients should be monitored for hypermanganesemia if they receive Mn in their TPN for >30 days. A 500 µg/d dose of Mn is probably excessive, and 100 µg/d should probably never be exceeded. Mn should be eliminated from the solution if the Mn level is elevated and should not be readministered unless the level returns to normal or subnormal. Mn should not be supplemented if the patient has liver disease with an elevated bilirubin. (Journal of Parenteral and Enteral Nutrition 23:333-336, 1999)

Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 6, 333-336 (1999)
DOI: 10.1177/0148607199023006333


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. J. Klein, F. H. Nielsen, and P. B. Moser-Veillon Trace Element Loss in Urine and Effluent Following Traumatic Injury JPEN J Parenter Enteral Nutr, March 1, 2008; 32(2): 129 - 139. [Abstract] [Full Text] [PDF]

				M. P. Fuhrman Micronutrient Assessment in Long-Term Home Parenteral Nutrition Patients Nutr Clin Pract, December 1, 2006; 21(6): 566 - 575. [Abstract] [Full Text] [PDF]

				Y. Takagi, A. Okada, K. Sando, M. Wasa, H. Yoshida, and N. Hirabuki Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition Am. J. Clinical Nutrition, January 1, 2002; 75(1): 112 - 118. [Abstract] [Full Text] [PDF]

				D. C. Dorman, M. F. Struve, R. A. James, B. E. McManus, M. W. Marshall, and B. A. Wong Influence of Dietary Manganese on the Pharmacokinetics of Inhaled Manganese Sulfate in Male CD Rats Toxicol. Sci., April 1, 2001; 60(2): 242 - 251. [Abstract] [Full Text] [PDF]

				Y. Takagi, A. Okada, K. Sando, M. Wasa, H. Yoshida, and N. Hirabuki On-Off Study of Manganese Administration to Adult Patients Undergoing Home Parenteral Nutrition: New Indices of In Vivo Manganese Level JPEN J Parenter Enteral Nutr, March 1, 2001; 25(2): 87 - 92. [Abstract] [PDF]

				S. Misra and D. F. Kirby Invited Review: Micronutrient and Trace Element Monitoring in Adult Nutrition Support Nutr Clin Pract, June 1, 2000; 15(3): 120 - 126. [Abstract] [PDF]